Activity of Dabrafenib/Trametinib Combo in Patients With Melanoma Brain Metastases

June 19, 2017
Georgina V. Long, BSc, PhD, MBBS

Georgina V. Long, BSc, PhD, MBBS, professor of medical melanoma oncology, Melanoma Institute Australia, discusses the activity seen with the combination of dabrafenib and trametinib for the treatment of patients with melanoma brain metastases.